The benchmark S&P 500 (SP500) pushed into uncharted territory once again on Thursday, notching a fresh all-time high as ...

Omega Healthcare Investors' (OMI) tenant Genesis Healthcare (GENN) gets stalking horse bid from ReGen Healthcare after filing ...

The ClearBridge Sustainability Leaders Strategy outperformed its Russell 3000 Index benchmark in the second quarter. Read ...

By Clive Maund The uptrend in silver is gathering pace.On its latest 6-month chart, we can see that, after breaking sharply ...

Mereo BioPharma Group plc's ORBIT study for setrusumab in osteogenesis imperfecta moves to final analysis by 2025. Click for ...

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

I’m Laura Bennett, the writer behind Sophos Research. I started my career as a software engineer at Amazon, where I spent over five years working on large-scale distributed systems and backend ...